search

Moderna announces start of COVID-19 vaccine trials for children

US manufacturer Moderna says it has started COVID-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.

“We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada,” says CEO Stephane Bancel in a statement.

“This pediatric study will help us assess the potential safety and immunogenicity of our COVID-19 vaccine candidate in this important younger age population.”

Boxes containing the Moderna COVID-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch, Mississippi, Dec. 20, 2020. (AP Photo/Paul Sancya, Pool)
comments